May 20, 2020
COVID-19 is here and is not vanishing anytime soon from our lives as suggested by health bodies, scientists, and researchers. It’s almost been six months since the outbreak occurred in China last year, and countries are still figuring out various ways to overcome its transmission. Though the countries around the wo...
Read More...
The Next Wave of Radioligand Therapies: 5 Candidates to Watch
Mar 20, 2026
Emerging TIL Therapies Poised to Broaden the Landscape Beyond AMTAGVI
Mar 06, 2026
BYSANTI Approval Positions Vanda to Compete in the Antipsychotic Market
Mar 02, 2026
-Agonist.png "Toll-like Receptors Agonist")
Newsletter/Whitepaper